BIOPRO (DE) is the German regional state agency in Baden- Württemberg, which acts as a contact and implementation point of the regional government policies for bioeconomy, biotechnology, pharmaceutical industry and medical technology. The organisation contacted recently with the Steinbeis Innovation GmbH, which is the German project partner of STRIA South Transdanubian Regional Innovation Agency Nonprofit Ltd. (STRIA) in Medtech4 Europe (M4E) project. BIOPRO interested in the current activities of the M4E project and the project partners. First of all, BIOPRO would like to receive information on coordination and organization in clinical studies.
Source: https://www.bio-pro.de/en/biopro/mission
Regarding the German regional state agency current situation, they are building their own initiative the Clinical study guide BW (The emergency action of Baden-Württemberg establishes a central information point, which facilitates access to clinical study centres and provides information on the subject). BIOPRO would like to get inspiration from similar projects from other European regions. They also participate in the German action on clinical studies as key stakeholders in the M4E project.
Source0: https://www.cic-it.fr/cic-it-grenoble.php
Auvergne-Rhone-Alpes Region, the French lead partner of M4E already offered to help for BIOPRO in this matter. As a part of this, they encourage BIOPRO to take into consideration their relevant good practice: Clinical Investigation Center in Innovative Technology (https://www.interregeurope.eu/policylearning/good-practices/item/3302/clinical-investigation-center-in-innovative-technology/). BIOPRO examines the applicability of the French good practice within its own administrative area.
Furthermore, STRIA also contacted the University of Pécs Clinical Centre and indicated the intention to cooperate for BIOPRO on behalf of STRIA and the clinic.
The Medtech4 Europe project is co-financed by the European Regional Development Fund and Hungary within the Interreg Europe Programme.
.